Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GLP1R | P43220 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.32 |
| ▸ | CDK2 | P24941 | 1/20 | 0.32 |
| ▸ | CDK7 | P50613 | 1/20 | 0.32 |
| ▸ | CCNH | P51946 | 1/20 | 0.32 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.32 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20164670 | 1.00 | ALDH1A1 (0.35) | ALDH1A1GLP1RMEN1KMT2ANPSR1 | |
| SCHEMBL20164579 | 1.00 | ALDH1A1 (0.35) | ALDH1A1GLP1RMEN1KMT2ANPSR1 | |
| SCHEMBL20164315 | 0.82 | MEN1 (0.34) | GLP1RMEN1KMT2ACCNE1CDK2 | |
| SCHEMBL20164319 | 0.82 | MEN1 (0.34) | GLP1RMEN1KMT2ACCNE1CDK2 | |
| SCHEMBL20164703 | 0.82 | MEN1 (0.34) | GLP1RMEN1KMT2ACCNE1CDK2 | |
| Hydrochloric Acid SCHEMBL20164720 | 0.81 | MEN1 (0.33) | MEN1KMT2ANPSR1CCNE1CDK2 | |
| Hydrochloric Acid SCHEMBL20164681 | 0.81 | MEN1 (0.33) | MEN1KMT2ANPSR1CCNE1CDK2 | |
| Hydrochloric Acid SCHEMBL20164682 | 0.81 | MEN1 (0.33) | MEN1KMT2ANPSR1CCNE1CDK2 | |
| SCHEMBL20164648 | 0.80 | KMT2A (0.43) | KMT2ALMNA | |
| SCHEMBL20164422 | 0.79 | ESR1 (0.33) | CCNE1CDK2CDK7CCNHCDK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3316890-B1 | NOVEL BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF MAKING AND USING SAME | NEURAD LTD (IL) | 2023-09-06 | — | — | EP | disclosed |
| US-10294228-B2 | Breathing control modulating compounds, and methods of making and using same | NEURAD LTD. (IL) | 2019-05-21 | — | — | US | disclosed |
| US-20180141953-A1 | Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same | NEURAD LTD. (IL) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180141953-A1 | Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same | MTNR1B, CHRM3, PER2 | ALDH1A1 2164/4885GLP1R 3766/4885MEN1 2683/4885 |
| US-10294228-B2 | Breathing control modulating compounds, and methods of making and using same | MTNR1B, PDE3A, CHRM3 | ALDH1A1 2004/4885GLP1R 4209/4885MEN1 2347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.